arrow
Z

Zhengbo Song

Zhejiang Cancer Hospital
H指数:35
被引数:3,981

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial

伊菲贝替尼联合加索拉西布治疗既往治疗过的KRASG12C突变型转移性结直肠癌:一项多中心、随机、1b/2期临床试验

2026-08-010
PRE
Garsorasib in Patients with KRAS G12C-Mutated Non-Small-Cell Lung Cancer: A Pooled Analysis of Phase 1/2 Study

Garsorasib 在 KRAS G12C 突变非小细胞肺癌患者中的研究:一项 I/II 期研究合并分析

2025-11-290
PRE
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

glecirasib在KRAS G12C突变实体瘤中的有效性和安全性:两项I/II期试验的合并分析

2025-10-020
OAAI
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study

SHR-A1811(抗体药物偶联物)在晚期HER2突变非小细胞肺癌中的应用:一项多中心、开放标签、I/II期研究

2024-07-150
OAAI